NFQ Level 9, Major Award
The MEngSc in Pharmaceutical and Biopharmaceutical Engineering is a full-time programme running for 12 months from the date of first registration for the programme or a part-time programme programme running for a minimum of 24 months (maximum 60 months) from the date of first registration for the programme.
In Part I students take modules to the value of 60 credits.
Part II consists of a Dissertation to the value of 30 credits. The choice of modules is subject to the approval of the Programme Director.
Candidates who satisfy the programme eligibility criteria may, subject to the approval of the Programme Coordinator, be permitted to take individual modules, as part of UCC's commitment to Continuing Professional Development (CPD), and be provided with a relevant transcript of marks.
Postgraduate Diploma in Pharmaceutical and Biopharmaceutical Engineering
Students who pass all modules in Part I but fail to achieve the requisite grade of 50% across the taught modules will be eligible for the award of a Postgraduate Diploma in Pharmaceutical and Biopharmaceutical Engineering. A candidate who passes Part I of the programme and who does not wish to proceed to Part II, may opt to be conferred with a Postgraduate Diploma in Pharmaceutical and Biopharmaceutical Engineering.
For information about modules, module choice, options and credit weightings, please go to Programme Requirements.